Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin-Reference-Cited by-同舟云学术

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

Published:2021-02 Issue:2 Volume:5 Page:308-313
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Boonyawat Kochawan¹,Lensing Anthonie W. A.²,Prins Martin H.³,Beyer‐Westendorf Jan⁴⁵,Prandoni Paolo⁶,Martinelli Ida⁷^ORCID,Middeldorp Saskia⁸^ORCID,Pap Akos F.²,Weitz Jeffrey I.⁹¹⁰,Crowther Mark¹⁰

Affiliation:

1. Department of Medicine Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

2. Bayer Healthcare Wuppertal Germany

3. Department of Clinical Epidemiology and Medical Technology Assessment Maastricht University Medical Center Maastricht The Netherlands

4. Department of Medicine I Division of Hematology and Hemostaseology University Hospital "Carl Gustav Carus" Dresden Dresden Germany

5. King's Thrombosis Service Department of Hematology King’s College London London UK

6. Arianna Foundation on Anticoagulation Bologna Italy

7. Fondazione IRCCS Ca' Granda‐Ospedale Maggiore PoliclinicoA. Bianchi Bonomi Hemophilia and Thrombosis Center Milano Italy

8. Department of Vascular Medicine Amsterdam Cardiovascular Sciences, Amsterdam UMCUniversity of Amsterdam Amsterdam The Netherlands

9. Thrombosis & Atherosclerosis Research Institute and McMaster University Hamilton ON Canada

10. Department of Medicine McMaster University Hamilton ON Canada

Funder

Bayer

Janssen Research and Development

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12474

Reference12 articles.

1. National Institute for Health and Care Excellence.Heavy menstrual bleeding. NICE Quality Standard 47. London: NICE; 2018. Available fromhttps://www.nice.org.uk/guidance/qs47/chapter/Introduction

2. Effect of warfarin on menstruation and menstrual management of the adolescent on warfarin

3. Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin

4. Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism

5. Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Die starke Monatsblutung: Behandeln wir richtig?;Journal für Gynäkologische Endokrinologie/Schweiz;2024-06-26

2. Starving in the land of plenty: the challenge of studying menstruation in anticoagulated patients;Research and Practice in Thrombosis and Haemostasis;2024-05

3. Incidence and Impact on Quality of Life of Heavy Menstrual Bleeding in Women on Oral Anticoagulant Therapy;Clinical and Applied Thrombosis/Hemostasis;2024-01

4. Effects of antiplatelet therapy on menstrual blood loss in reproductive-aged women: a systematic review;Research and Practice in Thrombosis and Haemostasis;2024-01

5. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis;Stroke;2023-11